drugset / Trial / NCT06879782
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
Phase 3
Recruiting
820 enrolled
Lunan Better Pharmaceutical Co., LTD.
Beijing Tongren Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of Lifitegrast Ophthalmic Solution.
Timeline
- Start
- 2024-03-28
- Primary completion
- 2026-03-28
- Completion
- 2026-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lifitegrast | Unknown | — | Other |